Follow The Filings

UTMD Utah Medical Products

Utah Medical Products earnings company data as of 12:58 PM ET 10/23

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 22 Oct EPS — 0.82 —
Rev — $1.4M —

Insider trades

Open-market buys and sales by UTMD's executives, directors and 10% owners in the last 12 months, from their Form 4s

All UTMD insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 2 gifts.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 2.02,9.01
8-K 7.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q UTAH MEDICAL PRODUCTS INC - FORM 10-Q SEC FILING
8-K 2.02,9.01
SCHEDULE 13G/A —
10-Q UTAH MEDICAL PRODUCTS INC - FORM 10-Q SEC FILING
8-K 5.07
8-K 2.02,9.01
DEF 14A PROXY STATEMENT
SCHEDULE 13G/A —
10-K UTAH MEDICAL PRODUCTS INC - FORM 10-K SEC FILING
8-K 2.02,9.01
10-Q UTAH MEDICAL PRODUCTS INC - FORM 10-Q SEC FILING
8-K 5.02,8.01,9.01
8-K 2.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q UTAH MEDICAL PRODUCTS INC - FORM 10-Q SEC FILING
8-K 2.02,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —
10-Q UTAH MEDICAL PRODUCTS INC - FORM 10-Q SEC FILING
SCHEDULE 13G —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.